GENEVA, 15 July 2025–Lenacapavir–a long-acting, six-monthly injectable antiretroviral medicine manufactured by Gilead Sciences–is now recommended by the World Health Organization as an additional HIV ...

In January the Government of Fiji declared an HIV outbreak in response to the sharp increase in new diagnoses. Although its HIV Surge Strategy seeks to rapidly expand HIV testing and treatment, most ...

UNAIDS emphasizes that every dollar invested in the HIV response not only saves lives but strengthens health systems and promotes broader development goals. Since the start of the epidemic, 26.9 ...

A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large ...

Documents Caribbean — Regional profile — 2025 Global AIDS Update — AIDS, Crisis and the Power to Transform 10 July 2025 ...

GENEVA/JOHANNESBURG, 10 July 2025—UNAIDS today launched its 2025 Global AIDS Update, AIDS, Crisis and the Power to Transform, which shows that a historic funding crisis is threatening to unravel ...

Borey and Sophia are among the first clients in Cambodia to begin long-acting injectable Cabotegravir (CAB-LA), a PrEP ...

GENEVA, 4 July 2025— It is with profound sadness that UNAIDS learns of the passing of the former Deputy President of the ...

A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large ...

GENEVA, 25 June 2025 — UNAIDS and Flanders have strengthened their joint efforts to combat the AIDS pandemic in Africa by ...

Feature Story “If funding is not restored or replaced, our progress will be lost” - UNAIDS Country Director in Tajikistan amid funding cuts for the HIV response 29 May 2025 ...